$Applied DNA Sciences (APDN.US)$ H.C. Wainwright has lowered...
$Applied DNA Sciences (APDN.US)$ H.C. Wainwright has lowered their price target for Applied DNA Sciences shares, while maintaining a Buy rating.
A public offering is expected to generate approximately $12 million in gross proceeds. Lastly, the company received approval from the New York State Department of Health for its pharmacogenomic testing service, TR8, and plans to implement a reverse stock split to comply with Nasdaq's listing rules.
A public offering is expected to generate approximately $12 million in gross proceeds. Lastly, the company received approval from the New York State Department of Health for its pharmacogenomic testing service, TR8, and plans to implement a reverse stock split to comply with Nasdaq's listing rules.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
104294070 OP : Public offering is comming